Natamycin approved--first U.S. drug for fungal keratitis.
D005128:Eye Diseases / Q000188:drug therapy; D006801:Humans; D007634:Keratitis / Q000188:drug therapy*; D009181:Mycoses / Q000188:drug therapy*; D010866:Natamycin / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D010866:Natamycin